Amy Simon - Net Worth and Insider Trading

Amy Simon Net Worth

The estimated net worth of Amy Simon is at least $1 Million dollars as of 2025-04-12. Amy Simon is the Chief Medical Officer of Beam Therapeutics Inc and owns about 65,742 shares of Beam Therapeutics Inc (BEAM) stock worth over $1 Million. Details can be seen in Amy Simon's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Amy Simon has not made any transactions after 2025-04-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Amy Simon

To

Amy Simon Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Amy Simon owns 1 companies in total, including Beam Therapeutics Inc (BEAM) .

Click here to see the complete history of Amy Simon’s form 4 insider trades.

Insider Ownership Summary of Amy Simon

Ticker Comapny Transaction Date Type of Owner
BEAM Beam Therapeutics Inc 2025-04-02 Chief Medical Officer

Amy Simon Latest Holdings Summary

Amy Simon currently owns a total of 1 stock. Amy Simon owns 65,742 shares of Beam Therapeutics Inc (BEAM) as of April 2, 2025, with a value of $1 Million.

Latest Holdings of Amy Simon

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BEAM Beam Therapeutics Inc 2025-04-02 65,742 15.47 1,017,029

Holding Weightings of Amy Simon


Amy Simon Form 4 Trading Tracker

According to the SEC Form 4 filings, Amy Simon has made a total of 6 transactions in Beam Therapeutics Inc (BEAM) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Beam Therapeutics Inc is the sale of 30,563 shares on April 2, 2025, which brought Amy Simon around $547,689.

Insider Trading History of Amy Simon

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Amy Simon Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Amy Simon Ownership Network

Ownership Network List of Amy Simon

No Data

Ownership Network Relation of Amy Simon

Insider Network Chart

Amy Simon Owned Company Details

What does Beam Therapeutics Inc do?

Who are the key executives at Beam Therapeutics Inc?

Amy Simon is the Chief Medical Officer of Beam Therapeutics Inc. Other key executives at Beam Therapeutics Inc include President & CSO Giuseppe Ciaramella , director & CEO John M. Evans , and Chief Legal Officer Christine Bellon .

Beam Therapeutics Inc (BEAM) Insider Trades Summary

Over the past 18 months, Amy Simon made 4 insider transaction in Beam Therapeutics Inc (BEAM) with a net sale of 58,948. Other recent insider transactions involving Beam Therapeutics Inc (BEAM) include a net sale of 258,765 shares made by John M. Evans , a net sale of 22,608 shares made by Christine Bellon , and a net sale of 114,188 shares made by Giuseppe Ciaramella .

In summary, during the past 3 months, insiders sold 113,636 shares of Beam Therapeutics Inc (BEAM) in total and bought 0 shares, with a net sale of 113,636 shares. During the past 18 months, 1,372,228 shares of Beam Therapeutics Inc (BEAM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,372,228 shares.

Beam Therapeutics Inc (BEAM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Beam Therapeutics Inc Insider Transactions

No Available Data

Amy Simon Mailing Address

Above is the net worth, insider trading, and ownership report for Amy Simon. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Amy Simon's mailing address is: Cambridge Ma 02142.